Analystreport

Orchard Therapeutics plc (NASDAQ: ORTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $14.00. They now have an "overweight" rating

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report